Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on developing best-in-class DNA-based therapeutics for rare genetic diseases, announced today that John Monahan, Ph.D., a veteran CEO of biotechnology and gene therapy companies, has joined its Scientific Advisory Board.
Help employers find you! Check out all the jobs and post your resume.